-
15661
SBRT for bridging and downstaging HCC before transplant
Published 2025-08-01“…Most patients had compensated liver function pre-SBRT and were treated with a median SBRT dose of 36 Gy in six fractions. …”
Get full text
Article -
15662
The efficacy, safety and clinical feasibility of a percutaneous atrial septal shunt device for pulmonary arterial hypertension: a single-center cohort study
Published 2025-02-01“…The primary endpoints of the study included the rate of major cardiovascular and cerebrovascular adverse events (MACCEs), serious adverse events (SAEs), and serious device-related adverse events (SADEs) within 12 months of shunt implantation. Data analysis was conducted using SAS 9.3. Results A total of 12 patients were enrolled in the study and successfully completed the operation. 10 subjects had completed 12 months’ follow-up after operation, while two subjects had died. …”
Get full text
Article -
15663
Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trialResearch in context
Published 2025-10-01“…The current findings provide data in a large sample of bvFTD that might be useful for the design of future clinical trials. …”
Get full text
Article -
15664
Response‐adapted zanubrutinib and tislelizumab as a potential strategy to enhance CD19 CAR T‐cell therapy in relapsed/refractory large B‐cell lymphoma: A retrospective observationa...
Published 2025-04-01“…Genomic and transcriptomic data indicated that this regimen was effective across genetic subtypes and abrogated T‐cell exhaustion within the TME. …”
Get full text
Article -
15665
Inhibitory effect of chlorogenic acid extract from peach blossoms on growth of Monilinia fructicola
Published 2025-06-01“…M. fructicola was cultured on potato dextrose agar (PDA) medium, and mycelium plugs (7 mm diameter) were treated with varying concentrations of CGA extracts (0.2, 0.3 or 0.4 mg·mL-1) or chlorogenic acid standard. …”
Get full text
Article -
15666
Jing-Yin-Gu-Biao formula protects mice from postinfluenza Staphylococcus aureus infection by ameliorating acute lung injury and improving hypercoagulable state via inhibiting NETos...
Published 2025-03-01“…Single cell RNA-sequencing (scRNA-seq) data indicated that neutrophils had the highest cytokine score in lungs and JYGBF inhibited neutrophil chemotaxis, reactive oxygen species (ROS) biosynthesis and ERK1/2 cascades in neutrophils. …”
Get full text
Article -
15667
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in early breast cancer post-treatment follow-up (EMINENT): a single-cent...
Published 2025-03-01“…Feasibility and effectiveness outcome measures, including health-related quality of life (primary outcome), physical activity and nutrition, patient experience, and financial toxicity were collected at baseline, and at 3-, 6-, and 12-months, with health service utilisation data at 24-months. Bivariate and multivariable, intention-to-treat analyses were conducted. …”
Get full text
Article -
15668
Ruxolitinib as a treatment strategy for SARS-CoV-2 pneumonia: clinical experience in a real-world setting
Published 2022-01-01“…Methodology: We analysed the data obtained by an observational cohort of patients with SARS-CoV-2 pneumonia treated with ruxolitinib in 22 hospitals of Mexico. …”
Get full text
Article -
15669
Potential active ingredients and mechanisms of Shufeitie ointment in the treatment of chronic obstructive pulmonary disease by integrating transdermal chemistry and network pharmac...
Published 2025-07-01“…To predict the potential mechanisms by which SFTOT may treat COPD, network pharmacology was used to construct a component-target-collaterals network. …”
Get full text
Article -
15670
RO5126766 attenuates osteoarthritis by inhibiting osteoclastogenesis and protecting chondrocytes through mediating the ERK pathway
Published 2025-05-01“…Background: Osteoarthritis (OA) is a degenerative joint disease that remains challenging to treat due to lack of complete understanding of its pathogenesis. …”
Get full text
Article -
15671
The spiritual needs and care of children and young people with life-threatening or life-shortening conditions, and parents (SPARK): a mixed-method investigation
Published 2025-05-01“…Design and research participants A mixed-method, multicomponent design was used with the quantitative and qualitative data collected. There were four work packages. Work package 1: survey of chaplaincy services in the National Health Service acute trusts in England (n = 98/136). …”
Get full text
Article -
15672
Pre-existing oncohematological disease in kidney transplant recipients: impact on graft survival, acute rejection, and long-term clinical outcomes
Published 2025-08-01“…IntroductionOncohematological disorders are heterogeneous conditions that present significant challenges in management prior to transplantation. Data about rejection risk, disease recurrence, eligibility criteria, and requested remission time before kidney transplant (KT) are still lacking.MethodsAll KTRs between January 1, 2000, and March 31, 2023 (n = 2871) were analyzed. …”
Get full text
Article -
15673
Increase in colonic propionate as a method of preventing weight gain in adults aged 20–40 years: iPREVENT, a multicentre, double-blind, randomised, parallel-group trial
Published 2025-07-01“…Due to the COVID-19 lockdowns and pivot to collection of self-reported weight data, the ‘Principal weight’ measurement for the primary outcome consists of 38% self-reported weight data. …”
Get full text
Article -
15674
Luspatercept for the treatment of lower-risk myelodysplastic syndrome with SF3B1 mutation: a real-world single-center research in China
Published 2025-12-01“…Background Luspatercept, approved by the FDA and EMA for patients with transfusion-dependent lower-risk myelodysplastic syndrome (LR-MDS) unresponsive to erythropoiesis-stimulating agents (ESAs), lacks extensive real-world data, particularly in China.Methods We retrospectively analyzed 14 LR-MDS-SF3B1 patients treated with luspatercept for ≥12 weeks.Results Median age was 60 years (range 47-72); 42.9% were male. …”
Get full text
Article -
15675
Exploration of fecal microbiota in newly diagnosed patients with inflammatory bowel disease using shotgun metagenomics
Published 2025-07-01“…Previous microbiota studies in IBD generally have involved patients treated with immunosuppressive agents, which can affect the results. …”
Get full text
Article -
15676
Local elections 2000: analyzing the results of the elections
Published 2000-04-01“…Not a few statistical data is presented in the work. Author postulates that the elections have elucidated the processes ongoing in the party system and the leaders of the political powers. …”
Get full text
Article -
15677
The transcription factor PbeNAC83 positively regulates the Valsa canker resistance in apple and pear
Published 2025-08-01“…[Methods] Based on transcriptome data, we screened PbeNAC83(Chr9.g47397) and performed bioinformatics analysis on it. …”
Get full text
Article -
15678
Screening of reference genes in Callosobruchus maculatus (Coleoptera: Bruchidae) fourth-instar larvae under high-temperature and antibiotic treatments(高温及抗生素处理下四纹豆象四龄幼虫内参基因的筛选)...
Published 2025-06-01“…HSP70 expression levels showed significant differences (P<0.05) between the high-temperature-treated group and the control group after normalization to RpL39_1 or RpL39_2. …”
Get full text
Article -
15679
Predictors of Recurrence After Curative Surgery for Stage I Colon Cancer: Retrospective Cohort Analysis of the Italian Society of Surgical Oncology Colorectal Cancer Network Collab...
Published 2024-12-01“…Given the low risk of recurrence of stage I CC, some international guidelines do not recommend intensive follow-up after surgery. However, data on the actual incidence, risk factors, and site of recurrences are scarce. …”
Get full text
Article -
15680
Long-term outcome in Wiskott-Aldrich syndrome and X-linked thrombocytopenia patients: an observational -prospective multi-center study of the Italian Primary Immune Deficiency Netw...
Published 2025-06-01“…Considering the cut-off date year 2000, it improved to >80%. Patients with WAS treated by haploidentical HSCT with αβTCRT-/CD19 B-cell depletion or gene therapy showed 100% survival at 5 years. …”
Get full text
Article